ZFP36 and breast cancer: Numerous reports have shown that TTP/ZFP36 downregulation is associated with breast cancer progression and/or treatment resistance (Marderosian et al., 2006; Brennan et al., 2009; Al-Souhibani et al., 2010; Griseri et al., 2011; Goddio et al., 2012; Upadhyay et al., 2013; Canzoneri et al., 2020).